Diabetic Neuropathy in Spinal Cord Stimulator Patients
The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.
Conditions studied
Diabetes Mellitus, Neuropathy, Neuropathic Pain, Vascular Diseases, Vascular Stiffness, Microvascular Changes, Pain, Chronic
About this study
The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.
Primary outcomes
- Improve vascular changes (6 Weeks)
- Vascular improvement on lower extremities with the Ankle Brachial Index (ABI) (6 weeks)
- Vascular improvement on lower extremities with the Toe Brachial Index (TBI) (6 Weeks)
- Vascular improvement on lower extremities with the Doppler Flowmetry (6 Weeks)
Eligibility information
Study locations
- University of Chicago Medical Center, Chicago, Illinois 60637 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.